Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer
Holger Heyn(Scope Group (United States)), Manel Esteller(Institució Catalana de Recerca i Estudis Avançats), Raquel Boqué-Sastre(Institut d'Investigació Biomédica de Bellvitge), Charles Y. Lin(Kronos Bios (United Kingdom)), Humberto J. Ferreira(University of Bonn), José V. Sánchez‐Mut(Institut d'Investigació Biomédica de Bellvitge), Anna Martínez‐Cardús(Institut d'Investigació Biomédica de Bellvitge), Sebastián Morán(Institut d'Investigació Biomédica de Bellvitge), Ramón Martínez(BG University Hospital Bergmannsheil Bochum), Antonio Gómez(Universitat de Vic - Universitat Central de Catalunya), Miguel Vizoso(Institut d'Investigació Biomédica de Bellvitge), Marta Gut(Centro Nacional de Análisis Genómico), Sònia Guil(Josep Carreras Leukaemia Research Institute), Sergi Sayols(Institute of Molecular Biology), David Torrents(Barcelona Supercomputing Center), Enrique Vidal(Leitat Technological Center), Modesto Orozco(Institute for Research in Biomedicine), Richard A. Young(Whitehead Institute for Biomedical Research), Romina Royo(Barcelona Supercomputing Center)
Cited by 226
Related Papers
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
|Cell|2018|2.4k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k